Abstract
About one-fifth of all gastrointestinal cancers are of pancreatic origin. More than 97% of these patients will die of the disease. The incidence of pancreatic cancer is highest between ages 50 and 70, men are more likely to develop it than women, and patients from disadvantaged social classes are more frequently affected. The etiology of pancreatic cancer is unclear, but some risk factors have been well known for a long time. Probably the most important risk factor is smoking; the risk is proportional to the amount of tobacco smoked. The majority of pancreatic cancers arise in the exocrine glandular areas of the pancreas. Eighty percent of these carcinomas correspond histologically to an adenocarcinoma. These carcinomas are generally ductal in origin and are mostly localized in the head of the pancreas. FDG-PET should be performed when the conventional work-up produces indeterminate results concerning the nature of the lesion or the presence of metastases, or if the different morphologic imaging modalities produce contradictory results [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Diederichs CG, Staib L, Vogel J, Glatting G, Glasbrenner B, Brambs H-J, Beger HG, Reske SN (2000) Values and limitations of FDG-PET in pancreatic masses. Pancreas (in press)
Diederichs CG, Sokiranksi R, Pauls S, Schwarz M, Guhlmann C, Glatting G, Glasbrenner B, Moller P, Beger HG, Brambs H-G, Reske SN (1999) Preoperative diagnosis of pancreatic tumors: what is the role of FDG-PET following endosonography (ES), ERCP, Spiral-CT (CT), and MRI? J Nucl Med 40/5 Suppl:104P
Fröhlich A, Diederichs CG, Staib L, Vogel J, Beger HG, Reske SN (1999) Detection of liver metastases from pancreatic cancer using FDG-PET. J Nucl Med 40:250–255
Neff CC, Simeone JF, Wittenberg J, Mueller PR, Ferrucci JT Jr. (1984) Inflammatory pancreatic masses: problems in differentiating focal pancreatitis from carcinoma. Radiology 150:35–38
Shreve PD (1998) Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease. Eur J Nucl Med 25:259–264
Zimny M, Buell U, Diederichs CG, Reske SN (1998) False-positive FDG-PET in patients with pancreatic masses: an issue of proper patient selection? Eur J Nucl Med 25:1352
Diederichs CG, Staib L, Glasbrenner B, Guhlmann A, Glatting G, Pauls S, Beger HG, Reske SN (1999) F-18 fluorodeoxyglucose (FDG) and C-reactive protein (CRP). Clin Pos Imaging Vol. 2(3): 131–136
Diederichs CG, Staib L, Glatting G, Beger HG, Reske SN (1998) FDG-PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. J Nucl Med 39:1030–1033
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Diederichs, C.G. (2000). Pancreatic Lesions. In: Bender, H., Palmedo, H., Biersack, HJ., Valk, P.E. (eds) Atlas of Clinical PET in Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59706-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-59706-0_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64093-3
Online ISBN: 978-3-642-59706-0
eBook Packages: Springer Book Archive